For most patients in steady-state weight loss or maintenance, 1ml weekly is sufficient
For example, BPC-157 was evaluated as a treatment for ulcerative colitis, not workout recovery
Tirzepatide has shown superior glycemic control compared to other GLP-1s, likely due to its dual action on GIP and GLP-1 receptors
You may find yourself putting down the fork a tad earlier than usual, or you may realize that you are not scouring for snacks as you did before between meals
Promotes sustainable, gradual weight loss : Unlike crash diets that leave you frustrated and depleted, GLP-1 works alongside your body to encourage gradual, steady progress
These are great questions, and the answers are more personal than you might think